KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Deferred Taxes (2016 - 2025)

Evolent Health has reported Deferred Taxes over the past 11 years, most recently at -$3.0 million for Q4 2025.

  • Quarterly results put Deferred Taxes at -$3.0 million for Q4 2025, down 183.22% from a year ago — trailing twelve months through Dec 2025 was -$3.0 million (changed 0.23% YoY), and the annual figure for FY2025 was -$3.0 million, changed 0.23%.
  • Deferred Taxes for Q4 2025 was -$3.0 million at Evolent Health, down from $627000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for EVH hit a ceiling of $777000.0 in Q4 2022 and a floor of -$68.7 million in Q1 2023.
  • Median Deferred Taxes over the past 5 years was -$551500.0 (2021), compared with a mean of -$7.3 million.
  • Peak annual rise in Deferred Taxes hit 426.47% in 2022, while the deepest fall reached 234185.0% in 2022.
  • Evolent Health's Deferred Taxes stood at -$238000.0 in 2021, then skyrocketed by 426.47% to $777000.0 in 2022, then plummeted by 2037.97% to -$15.1 million in 2023, then soared by 92.87% to -$1.1 million in 2024, then plummeted by 183.22% to -$3.0 million in 2025.
  • The last three reported values for Deferred Taxes were -$3.0 million (Q4 2025), $627000.0 (Q3 2025), and -$865000.0 (Q2 2025) per Business Quant data.